No Handouts for Drug Advertisements Act

United States119th CongressS-1785Senate
Updated: May 15, 2025

Summary

This bill proposes to amend the Internal Revenue Code of 1986 by adding a new section that would deny tax deductions for expenses related to direct-to-consumer advertising of certain prescription and compounded drugs. The legislation broadly defines "direct-to-consumer advertising" as any dissemination by or on behalf of a covered entity, primarily targeted to the general public, through various media including television, radio, internet, and billboards. However, advertisements published in professional journals and other periodicals are specifically excluded from this definition . The bill applies to amounts paid or incurred after its enactment date, effectively removing a tax incentive for drug manufacturers to promote specific medications directly to consumers.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-3010: No Handouts for Drug Advertisements Act

Referred to the House Committee on Ways and Means.

  1. Read twice and referred to the Committee on Finance.

    Senate

  2. Introduced in Senate

All available records shown.